Dr. Barbara Burton
Professor of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL
Dr. Barbara K. Burton is a Professor of Pediatrics at Northwestern University and an Attending Physician at Ann & Robert H. Lurie Children’s Hospital of Chicago. Board-certified in Pediatrics, Clinical Genetics, and Clinical Biochemical Genetics, she has contributed to over 300 peer-reviewed articles and 50 book chapters. Dr. Burton has been involved in clinical trials for genetic disorder therapies, including those leading to FDA approval of sapropterin and pegvaliase. She is a Past-President of the Society for Inherited Metabolic Disorders and the Chicago Pediatric Society. She has received numerous awards, including a Lifetime Achievement Award from the March of Dimes in 2018.
Dr. Cary O. Harding
Professor of Molecular & Medical Genetics and Pediatrics, Oregon Health & Science University (OHSU)
Dr. Cary O. Harding is a Professor of Molecular and Medical Genetics and Pediatrics at Oregon Health & Science University (OHSU). He earned his medical degree from the University of Washington and trained in pediatrics and medical genetics at the University of Wisconsin-Madison. Board-certified in Clinical Genetics and Clinical Biochemical Genetics, he is a founding fellow of ACMGG and a member of ASGCT and SSIEM. Dr. Harding is the treasurer of SIMD, attending physician at Doernbecher Children’s Hospital, and Medical Director of OHSU's Biochemical Genetics Lab. His research focuses on developing novel therapies, including gene and cell therapies, for inborn errors of metabolism.
Dr. Rani Singh
Professor of Human Genetics and Pediatrics, Emory University
Dr. Singh is a Professor of Human Genetics and Pediatrics at Emory University, specializing in inborn errors of metabolism (IEM). With over 30 years of research and clinical experience, her work focuses on newborn screening (NBS), genotype/phenotype relationships, and dietary treatments for IEM. She directs the MNT4P Program, funded by the Georgia Department of Public Health, and leads the INBS-LTFU Consortium, funded by HRSA. Dr. Singh has held leadership roles in organizations like SERGG and GMDI and co-directs the Georgia CTSA's Bionutrition Research Unit. Her efforts aim to improve health outcomes in children with IEM.